| Title | CNS and Neurological Disorders - Drug Targets |
| Abbreviation | CNS Neurol. Disord. - Drug Targets |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3) |
| h-index | 93 |
| Overall Rank/Ranking | 9006 |
| SCImago Journal Rank (SJR) | 0.574 |
| Impact Score | 2.87 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 18715273 |
| Best Quartile | Q2 |
| Coverage History | 2006-2022 |
CNS and Neurological Disorders - Drug Targets is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of CNS and Neurological Disorders - Drug Targets is 9006. According to SCImago Journal Rank (SJR), this journal is ranked 0.574. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 93. The best quartile for this journal is Q2.
The ISSN of CNS and Neurological Disorders - Drug Targets journal is 18715273. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS and Neurological Disorders - Drug Targets is cited by a total of 634 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of CNS and Neurological Disorders - Drug Targets is 2.87, which is computed in 2023 as per its definition. CNS and Neurological Disorders - Drug Targets IF is increased by a factor of 0.11 and approximate percentage change is 3.99% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of CNS and Neurological Disorders - Drug Targets is 2.87. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.87 |
| 2021 | 2.76 |
| 2020 | 3.87 |
| 2019 | 3.27 |
| 2018 | 2.29 |
| 2017 | 1.83 |
| 2016 | 2.47 |
| 2015 | 2.22 |
| 2014 | 2.49 |
CNS and Neurological Disorders - Drug Targets has an h-index of 93. It means 93 articles of this journal have more than 93 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of CNS and Neurological Disorders - Drug Targets is 18715273. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of CNS and Neurological Disorders - Drug Targets is 9006. According to SCImago Journal Rank (SJR), this journal is ranked 0.574. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.574 |
| 2021 | 0.561 |
| 2020 | 0.923 |
| 2019 | 0.832 |
| 2018 | 0.747 |
| 2017 | 0.863 |
| 2016 | 1.003 |
| 2015 | 0.894 |
| 2014 | 1.070 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9006 |
| 2021 | 8898 |
| 2020 | 4934 |
| 2019 | 5644 |
| 2018 | 6375 |
| 2017 | 5301 |
| 2016 | 4408 |
| 2015 | 5142 |
| 2014 | 3918 |
CNS and Neurological Disorders - Drug Targets is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of CNS and Neurological Disorders - Drug Targets is CNS Neurol. Disord. - Drug Targets. This abbreviation ('CNS Neurol. Disord. - Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
CNS and Neurological Disorders - Drug Targets latest impact IF is 2.87. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.87 (2020) and 1.83 (2017), respectively, in the last 9 years. Moreover, its average IS is 2.67 in the previous 9 years.
The CNS and Neurological Disorders - Drug Targets has an SJR (SCImago Journal Rank) of 0.574, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.070 in 2014 and the lowest being 0.561 in 2021. Furthermore, the average SJR of the CNS and Neurological Disorders - Drug Targets over the previous 9-year period stands at 2.67.
The latest h-index of the CNS and Neurological Disorders - Drug Targets is 93.
The CNS and Neurological Disorders - Drug Targets is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The CNS and Neurological Disorders - Drug Targets is currently ranked 9006 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3918 in 2014 and its lowest position of 9006 in 2022.
The standard ISO4 abbreviation for the CNS and Neurological Disorders - Drug Targets is CNS Neurol. Disord. - Drug Targets.
CNS and Neurological Disorders - Drug Targets is classified as a journal that the Bentham Science Publishers B.V. publishes.
The CNS and Neurological Disorders - Drug Targets encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The CNS and Neurological Disorders - Drug Targets is assigned the following International Standard Serial Numbers (ISSN): 18715273.
The best quartile for the CNS and Neurological Disorders - Drug Targets is Q2 (2022).
The CNS and Neurological Disorders - Drug Targets coverage history can be summarized as follows: 2006-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Entrepreneurship Theory and Practice | journal | 338 | Wiley-Blackwell | 185 | 12.75 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Sex Education | journal | 5168 | Routledge | 41 | 2.82 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Biological Procedures Online | journal | 3350 | BioMed Central Ltd. | 43 | 6.40 |
| Journal of Imaging Science and Technology | journal | 19249 | Society for Imaging Science and Technology | 44 | 0.96 |
| Canadian Journal of Mathematics | journal | 3905 | Canadian Mathematical Society | 43 | 0.79 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.87 |
| 2021 | 2.76 |
| 2020 | 3.87 |
| 2019 | 3.27 |
| 2018 | 2.29 |
| 2017 | 1.83 |
| 2016 | 2.47 |
| 2015 | 2.22 |
| 2014 | 2.49 |
